Carroll Financial Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$2K Sell
42
-39
-48% -$2.31K ﹤0.01% 1491
2021
Q3
$4K Buy
81
+39
+93% +$2.14K ﹤0.01% 1430
2021
Q2
$2K Hold
42
﹤0.01% 1577
2021
Q1
$1K Sell
42
-304
-88% -$12.8K ﹤0.01% 1583
2020
Q4
$12K Hold
346
﹤0.01% 1060
2020
Q3
$12K Hold
346
﹤0.01% 993
2020
Q2
$12K Hold
346
﹤0.01% 992
2020
Q1
$12K Hold
346
﹤0.01% 898
2019
Q4
$14K Hold
346
﹤0.01% 969
2019
Q3
$12K Hold
346
﹤0.01% 948
2019
Q2
$10K Buy
+346
New +$10.3K ﹤0.01% 1021

Other funds holding PBH

Carroll Financial Associates's PBH Position: Q4 2021 in Review

Carroll Financial Associates reduced its Prestige Consumer Healthcare (PBH) stake by 48% in Q4 2021, selling an estimated $2.31K and leaving 42 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

Carroll Financial Associates first reported a position in PBH in Q2 2019 and has held it in 11 quarters since. The position peaked at $14K in Q4 2019. 272 funds tracked by Wall St. Rank hold PBH as of Q4 2021.

  • Carroll Financial Associates held 42 shares of Prestige Consumer Healthcare worth $2K as of Q4 2021.
  • Carroll Financial Associates sold 39 Prestige Consumer Healthcare shares in Q4 2021, an estimated $2.31K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1491 holding.
  • Carroll Financial Associates first reported a position in Prestige Consumer Healthcare in Q2 2019 and has held it in 11 quarters since.
  • Carroll Financial Associates's Prestige Consumer Healthcare position peaked at $14K in Q4 2019.
  • 272 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.